TRANSCENTA-B (06628.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Dec5

Crestone Group Discloses Clinical Trial Results of Osemitamab Combination Therapy

01:46

Sep26

11:54

Sep23

Qian Xueming Increases Holdings in Cytiva Group by 20,000 Shares

11:17

Sep22

CSG and Huajan Explore Blockchain Tokens to Fund Oncology Therapy Development

00:05

Sep17

Trinity-Group-B Completes Share Placement

09:11

Sep10

CrestaBio Plans to Raise About HKD 62.35 Million Through Share Placement

01:04

Schedules & Filings

Schedules

Filings

Aug27

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 1.484 M, Net Income -60.08 M, EPS -0.1476

Mar30

Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 3.562 M, Net Income -83.28 M, EPS -0.2061

Aug28

Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 2.452 M, Net Income -71.84 M, EPS -0.1771

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More